GlassScriptPhysician profile
Amber N Koon
NPI 1609288752
$209,670.19
in general payments reported to CMS, 2019-2025
17 companies · $89K in 2025
The $89K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.12 · 2020: $557 · 2021: $16K · 2022: $4,504 · 2023: $24K · 2024: $75K · 2025: $89K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $119K · Travel and Lodging: $45K · Consulting Fee: $11K · Food and Beverage: $9,362 · Education: $4,137 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500 · Gift: $14.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $119,003.00 |
| Travel and Lodging | $44,794.48 |
| Consulting Fee | $11,051.00 |
| Food and Beverage | $9,362.08 |
| Education | $4,137.38 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
| Gift | $14.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $184,104.40 | 2020-2025 | Phasix Mesh, Arista, Channel Drain |
| Intuitive Surgical, INC. | $21,994.22 | 2020-2025 | Da Vinci Surgical System |
| Becton, Dickinson and Company | $2,904.18 | 2023-2025 | Phasix Mesh |
| Endogastric Solutions, INC | $251.55 | 2019-2024 | Esophyx |
| Ethicon US, LLC | $146.79 | 2021-2024 | Stratafix, Surgicel Nu-Knit, Surgiflo Hemostatic Matrix |
| Conmed Corporation | $50.00 | 2023 | Airseal |
| Merck Sharp & Dohme LLC | $33.71 | 2022-2023 | Keytruda |
| Tela Bio, INC. | $26.58 | 2021-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Corium, LLC | $22.02 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $21.67 | 2022 | |
| Ambu INC. | $18.77 | 2022 | |
| Allergan, INC. | $16.83 | 2021 | |
| Organogenesis INC. | $16.45 | 2025 | Affinity |
| Lucid Diagnostics INC. | $16.12 | 2022 | |
| Solventum Corporation | $15.77 | 2024 | V.A.C.Instill, 3m Cavilon, Prevena |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $15.68 | 2025 | |
| Kci USA, INC. | $15.45 | 2023 | Promogran Prisma, Prevena, Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Koon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.